Skip to main content
. 2021 Nov 3;10(11):1756. doi: 10.3390/antiox10111756

Table 1.

Summary of the systemic characteristics of the study participants.

Variable (19–30)
Year
(31–50)
Year
(51–70)
Year
p-Value Post-Hoc
Number 16
10M:6F
16
8M:8F
10
4M:6F
- -
Age (years) 24.54 (1.74) 37.81 (1.57) 60.75 (2.22) 0.0001 * 1 < 2 < 3
SBP (mmHg) 115.27 (3.80) 114.7 (3.95) 118.5 (5.10) 0.82946 -
DBP (mmHg) 64.64 (2.54) 70.9 (2.67) 72.5 (3.44) 0.13002 -
HR (bpm) 63.17 (3.29) 68.1 (2.55) 66.18 (2.43) 0.50522 -
IOP (mmHg) 12.93 (0.57) 13.23 (0.60) 14.83 (0.80) 0.14723 -
BMI (kg/m2) 23.34 (1.13) 26.02 (1.19) 26.59 (1.53) 0.16039 -
Glucose (mmol/L) 4.41 (0.21) 4.99 (0.28) 4.68 (0.28) 0.26740 -
TG (mmol/L) 0.83 (0.065) 1.0 (0.081) 0.96 (0.088) 0.22376 -
CHOL (mmol/L) 3.95 (0.17) 4.14 (0.21) 4.93 (0.24) 0.0071 * 1 < 2 < 3
HDL-C (mmol/L) 1.33 (0.08) 1.44 (0.10) 1.25 (0.12) 0.50590 -
LDL-C (mmol/L) 2.28 (0.17) 2.60 (0.21) 3.01 (0.24) 0.01116 * 1 < 2 < 3
LDL-C/HDL-C 1.64 (0.13) 1.85 (0.2) 2.37 (0.19) 0.0658 1 = 2
3 > 1,2

Abbreviations: SBP, systolic blood pressure; DBP, diastolic blood pressure; HR, heart rate; IOP, intraocular pressure; BMI, body mass index; TG, triglycerides; CHOL, total cholesterol; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein. * Significant p-values are indicated where p < 0.05 was considered significant.